Authors
Professor of Clinical Neurology, University of Rochester Medical Center
Vice chair of research, Department of Opthalmology, NYU Langone
Associate Professor; Director of Outpatient Operations, Jefferson Headache Center; Co-Chief, Division of Headache, Jefferson University Hospital
Aging Incubator, New York University, in New York, New York
Director of Regulatory Affairs at the National MS Society.
Program Director, Multiple Sclerosis Fellowship; Neurologist, The Ohio State Neurological Institute
Speech-Language Pathologist, Brooks Rehabilitation Outpatient Clinic – Orange Park.
Senior editor, Practical Cardiology and Endocrinology Network
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Venglustat as First Therapy for Neurological Manifestations of Type 3 Gaucher Disease
2
FDA Approves Cemdisiran as New Treatment for Generalized Myasthenia Gravis
3
Phase 2 SPINOZA Trial to Test CETP Inhibitor Obicetrapib in APOE-Stratified Preclinical Alzheimer Disease
4
ALS Prevention, Gene Therapy, and Newborn Screening at MDA 2027
5
